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Approach for Treating Acute Mesenteric Ischemia?
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Vascular Research Group, Division of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Inﬁrmary, Leicester LE2 7LX, UK
T.L. Forbes, Associate Editor, Journal of Vascular Surgery
Division of Vascular Surgery, University of Toronto, Toronto, ON, CanadaAcute mesenteric ischemia continues to be a life-
threatening insult in often elderly patients with many
comorbidities. Recognition and correct diagnosis can be an
issue, leading to delays in therapy resulting in loss of bowel
and/or life. The basic surgical principals in treating acute
mesenteric ischemia have long been early recognition,resuscitation, urgent revascularization, resection of necrotic
bowel, and reassessment with second-look laparatomies.
Endovascular techniques now offer a less invasive alterna-
tive but it is unclear whether an endovascular ﬁrst or open
surgery ﬁrst approach is preferred in the majority of pa-
tients. Our discussants will attempt to clarify these issues.*Corresponding author.
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M. Björck
Institution of Surgical Sciences, Uppsala University, Uppsala, SwedenThis debate is to be as evidence based as possible. The ﬁrst
point to establish, however, is that there have been no
randomized controlled trials (RCTs) comparing an endovas-
cular ﬁrst versus an open surgery ﬁrst strategy for the
treatment of acute mesenteric ischemia (AMI), as there
have been for ruptured aortic aneurysm repair.1 Given that
AMI is relatively uncommon and usually presents as an
emergency, there probably never will be an RCT to study
this issue. However, according to the GRADE guidelines,2
data from observational studies can be valuable, provided
certain criteria are met, including that the risk of bias must
be minimized, data should be consistent, and confounding
factors need to be controlled for.
Most published reports are single-center series, with all
the methodological problems related to that type of study
design, in particular publication bias. A recent example is
from Kuopio University Hospital, Finland, which reported a
5-year consecutive series of patients with AMI, during
which time an endovascular ﬁrst strategy was applied,which was feasible in 88% of cases.3 Mortality was a
commendable 32% and in half of the cases where endo-
vascular therapy (EVT) failed, surgical bypass was ultimately
successful. These survival rates compare favorably with the
experience of the opponents of this debate (in another
single-center series), who reported 30-day mortality rates of
62% after the treatment of acute arterial thrombosis and
59% after arterial embolism, where a policy of open surgery
ﬁrst was the primary treatment strategy.4
One important group of patients with AMI are those who
develop acute upon chronic ischemia. In another publica-
tion from Endean’s group on the treatment of patients with
chronic mesenteric ischemia, high mortality rates are re-
ported in patients in whom a vein graft was used as the
bypass conduit (16% vs. 5% amongst those who had a
prosthetic graft; p ¼ .039).5 Patients in whom a vein graft
was used underwent emergency surgery more often (16%
vs. 4%; p ¼ .012) and more often had a contaminated
surgical site (30% vs. 7%; p ¼ .001). The authors concluded
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been prevented had the revascularization taken place more
expeditiously. A venous mesenteric bypass is known to be
more prone to kinking and occlusion. Interestingly, however,
the authors did not mention a natural alternative in this
situation, which would be ante- or retrograde stenting of
the superior mesenteric artery (SMA).6
Of greater practical interest (than single-center series) is
the analysis of population-based outcomes, which generally
avoid the problem of publication bias. Swedvasc, the
Swedish vascular registry, was founded in 1987 and cap-
tures >90% of all vascular surgical procedures in a country
with 9.5 million inhabitants. Swedvasc has published two
papers on outcomes following revascularization of the SMA
for AMI for the periods 1987e98 and 1999e2006.7,8
Overall, total surgical activity increased fourfold from 1999
to 2006, while the number of endovascular re-
vascularizations increased sixfold. Complete case records
were analyzed in 60 and 163 patients from the two time
periods, respectively.7,8 Overall mortality decreased from
the ﬁrst time period to the second but this decrease was
only observed in patients treated by EVT. Thirty-day and 1-
year mortality rates were 42% versus 28% (p ¼ .03) and
58% versus 39% (p ¼ .02) for open and endovascular sur-
gery, respectively. Long-term survival after endovascular
treatment was also better after EVT than after open surgery
(p ¼ .02). Could this difference be explained solely by dif-
ferences in case mix? Probably not, as the number of bowel
resections performed at the time of revascularization was
similar for the two cohorts and, in a multivariate analysis,
primary EVT was independently associated with survival
(odds ratio 3.7, 95% conﬁdence interval 1.2e11.6;
p ¼ .025). As was also observed in Kuopio, Finland, one of
the main reasons why a policy of primary EVT ﬁrst was
successful was the fact that most patients with a failed EVT
underwent successful open revascularization.
Further analyses of the Swedvasc Registry are ongoing,
but data from the latest time period (2009e15) are not yet
available. It has been noted, however, that from 2009 on-
wards, more than half of all arterial procedures for AMI
were endovascular, and it seems that an endovascular ﬁrst
strategy is more advantageous for patients with SMA
thrombosis than for patients with embolic occlusions.
Swedvasc observed no signiﬁcant difference in mortality
after embolic occlusions (37% vs. 33%), whereas the mor-
tality rate was signiﬁcantly higher after open than endo-
vascular treatment for thrombotic occlusions (56% vs.
23%).9
In another large population-based registry reporting from
the National Inpatient Sample (NIS) in the USA, a similar
time trend and similar differences in results were reported
by North American colleagues.10 The NIS is a database that
includes 20% of inpatient hospital episodes from approxi-
mately 1,000 US hospitals, and is considered to have high-
quality data. Among 679 patients with AMI treated be-
tween 2005e09, 514 (76%) underwent open and 165 (24%)
endovascular surgery. The proportion of patients with AMI
who underwent endovascular repair increased from 12% in2005 to 30% in 2009. Mortality was 39% after open
revascularization compared with 25% after endovascular
revascularization (p ¼ .006). Amongst survivors, the pro-
portion of patients who needed total parenteral nutrition
was also signiﬁcantly higher after open than after EVT (24%
vs. 14%; p ¼ .025).
Although level I evidence is lacking, observational data
like these are compelling. But why might an EVT ﬁrst
strategy be preferable in patients with AMI? There are
several possible explanations. First, it may be a better
“damage control” strategy to opt for EVT ﬁrst (usually under
local anesthesia), than opting for an emergency laparotomy
under general anesthesia. Avoiding prolonged general
anesthesia in these frail patients may be an important part
of damage control, as has been observed in patients un-
dergoing ruptured abdominal aortic aneurysm repairs.11
Second, EVT invariably involves a completion angiogram
to ensure that the revascularization has been completed to
the best possible standard. It is not uncommon for
adjunctive procedures such as percutaneous transluminal
angioplasty (PTA) or thrombolysis to be necessary as a
consequence of completion angiography. Completion angi-
ography could, of course, also be performed after open
surgery; however, when analyzing the contemporary
Swedish experience, it had not been performed in a single
patient.8 Third, EVT is, of course, a minimally invasive pro-
cedure, which may explain higher success rates, when
treating elderly, frail patients with small marginal physio-
logical reserves.
Paradoxically, it seems to be a greater challenge to get
patients with AMI treated (in the ﬁrst place) than to debate
about what is the “ideal” revascularization strategy. With
modern multislice computed tomography imaging tech-
nology, the ability to diagnose acute SMA occlusion should
not be difﬁcult, but the diagnosis has to be suspected ﬁrst.
In the US study, out of 23,744 patients presenting with AMI,
4,665 underwent some form of treatment, but only 679
patients underwent an open or endovascular revasculari-
zation, constituting only 3% of the entire cohort, and 15%
of those treated.10 It is known that approximately 70% of
patients with acute SMA occlusion will require revascular-
ization to survive (the remaining 30% can be saved by
bowel resection only),12 yet only a very small proportion of
patients with AMI will receive this live-saving treatment.
There are no parallel data from Sweden, or any other Eu-
ropean country, but revascularization strategies appear to
vary more than 10-fold between centers with high and low
surgical activity, despite similar populations, suggesting that
there is a similar problem in Europe (unpublished data).
Approximately one in seven patients with AMI has
venous thrombosis as their cause of ischemia, possibly one
in four according to the experience of the debate oppo-
nents.4 Primary treatment with heparin, followed by
catheter-directed thrombolysis if the clinical picture does
not improve, is the treatment of choice, despite the lack of
comparative data. Quoting the opponents, who wrote the
following: “There are anecdotal reports of venous throm-
bectomy, but this has not shown improved outcome and is
Table 1. The “endovascular ﬁrst” strategy for diagnosing and
treating acute intestinal ischemia.
After having diagnosed the condition, most often with multislice
computed tomography images, and if an acute occlusion of the
superior mesenteric artery (SMA) is diagnosed, the treatment is
organized in the following way:
1. The patient is taken to a hybrid operating room,
thereby providing the option for employing both
open and endovascular techniques. Angiography and
endovascular treatment is attempted, with access
from the groin and/or the brachial artery, preferably
under local anesthesia.
2. After endovascular revascularization, the abdomen is
evaluated and if there is any suspicion of bowel
gangrene, a laparotomy is performed; otherwise,
close surveillance follows for at least 48 h. If
percutaneous endovascular revascularization fails,
laparotomy and hybrid retrograde recanalization of
the SMA and stenting, or open revascularization
should be undertaken, without delay.
3. Completion angiography followed by adjunctive
endovascular procedures (where necessary),
including further aspiration embolectomy of SMA
branches, percutaneous transluminal angioplasty/
stenting of residual stenosis, and thrombolysis of
occluded side branches.
4. Second-look angiography and/or laparotomy may be
necessary, and should be performed liberally.
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the best route for thrombolysis is transjugular and through
a transjugular intrahepatic portosystemic shunt, improving
outﬂow.13,14 Furthermore, in AMI following aortic dissec-
tion, thoracic endovascular aortic repair and adjunct
endovascular methods are the preferred methods of
revascularization, which is undisputable.15
In conclusion, although level I evidence is lacking, high-
quality observational data appear to be consistent and
favor an endovascular ﬁrst strategy, preferably as a four-
stage procedure (Table 1). First, if SMA occlusion is sus-
pected/diagnosed, the patient should be taken to a hybrid
operating theatre for conﬁrmatory imaging and the option
of performing endovascular techniques, preferably under
local anesthesia. Second, if it is not possible to complete an
endovascular revascularization and/or there is a need to
visualize directly the bowel for resection, this is followed by
exploratory laparotomy, and (if necessary) retrograde
recanalization of the exposed SMA and ante-/retrograde
stenting of the artery,6 or open revascularization. Third, theprocedure is followed by completion angiography and (if
necessary) adjunctive endovascular interventions such as
aspiration, PTA, or thrombolysis. Fourthly (and very
importantly), second-look procedures should be performed
with a very low threshold for intervention.REFERENCES
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